OLR1 Emerges as Key Driver of Gastric Cancer Growth and Immune Evasion
A new study shows that the lipid receptor OLR1 drives gastric cancer progression by activating NF-κB signaling and polarizing macrophages ...
A new study shows that the lipid receptor OLR1 drives gastric cancer progression by activating NF-κB signaling and polarizing macrophages ...
A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to ...
A new Bayesian modelling study shows that although childhood Helicobacter pylori infections in China have fallen sharply since the 1980s, ...
Researchers in China have developed a Transformer-CNN deep learning framework that segments and grades gastric intestinal metaplasia in whole slide ...
A 12-year Japanese database study of 16,573 patients shows first-line nivolumab plus chemotherapy rapidly displaced cisplatin-based regimens in HER2-negative advanced ...
Gastric cancer may be exploiting a little-known metabolic molecule to disable the immune system, according to research from Keio University ...
In a groundbreaking development that could revolutionize the therapeutic landscape of gastric cancer, researchers have unveiled the pivotal role of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine